Sentence examples for unfavourable events from inspiring English sources

Falling behind schedule and having discrepancy between the as-built and designed baseline plans are unfavourable events that often occur in construction projects.

Unfavourable events for intraoral prosthesis are screw loosening and bar dislocation or screw fracture, obturator misfitting due to soft tissue remodelling, implant failure and prosthetic teeth fracture or excessive abrasion due to occlusal loss of balance [14].

The results suggest that deception is definitely promoted by unfavourable events, and that maintaining one's own reputation encourages honesty, particularly in socially inclined individuals.

These unfavourable events, including invasion of inflammatory and glial cells, secretion of inhibitors of axon growth, ongoing apoptosis of neural cells and demyelination and formation of cavities or cysts, culminate in glial scarring and loss of the complex nervous cytoarchitecture [5], [6], [7].

It is of great interest to see whether studies directed to lower glucose levels after admission lead to a reduction of unfavourable events and preservation of infarct-size.

Neoplasia-associated neoangio-genesis and neovascularization in diabetes and rheumatoid arthritis are unfavourable events, and improper angiogenesis is the subject of research in ischaemic disorders and atherosclerosis.

Having in mind the basic definition of risk, being the product of the probability and consequence, and fixing the consequence at the highest level, only probability of unfavourable event (leakage and/or failure) has been evaluated.

Thus, the loss of the tumour-suppressor PTEN may perhaps represent a prognostically unfavourable event also in PC (Loupakis et al, 2009; Feng et al, 2011).

Event-free survival (EFS) was defined as the interval between the date of the first endovesical instillation and the first unfavourable event, superficial disease, progression to infiltrating disease or the last visit.

In such cases, it has been shown that patients are often unable to correctly interpret their incremental chance of experiencing an unfavourable event compared to placebo, thus perceiving an overestimate of their total risk.

Time to progression was measured in all patients as the time (in months) from the start of study drug to the date of evidence of progressive disease or death (or last follow-up in absence of unfavourable event).